Y Intercept Hong Kong Ltd purchased a new stake in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 15,678 shares of the company’s stock, valued at approximately $154,000.
Other large investors have also added to or reduced their stakes in the company. BNP Paribas Financial Markets purchased a new position in shares of Ginkgo Bioworks in the third quarter valued at $1,287,000. Verition Fund Management LLC bought a new position in Ginkgo Bioworks during the third quarter valued at $792,000. PDT Partners LLC purchased a new position in shares of Ginkgo Bioworks in the 3rd quarter worth $1,199,000. Erste Asset Management GmbH bought a new stake in shares of Ginkgo Bioworks in the 3rd quarter worth about $4,075,000. Finally, Point72 Asia Singapore Pte. Ltd. raised its position in shares of Ginkgo Bioworks by 644.5% during the 3rd quarter. Point72 Asia Singapore Pte. Ltd. now owns 32,319 shares of the company’s stock valued at $263,000 after buying an additional 27,978 shares in the last quarter. Institutional investors own 78.63% of the company’s stock.
Ginkgo Bioworks Trading Up 1.7 %
DNA opened at $8.26 on Thursday. Ginkgo Bioworks Holdings, Inc. has a 12 month low of $5.26 and a 12 month high of $51.20. The stock has a 50-day moving average of $11.43 and a 200 day moving average of $9.42. The firm has a market cap of $474.49 million, a P/E ratio of -0.63 and a beta of 1.16.
About Ginkgo Bioworks
Ginkgo Bioworks Holdings, Inc, together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries.
Featured Articles
- Five stocks we like better than Ginkgo Bioworks
- How to Effectively Use the MarketBeat Ratings Screener
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- How to Find Undervalued Stocks
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- Airline Stocks – Top Airline Stocks to Buy Now
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for Ginkgo Bioworks Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ginkgo Bioworks and related companies with MarketBeat.com's FREE daily email newsletter.